File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Best practices on immunomodulators and biological agents for Ulcerative colitis and Crohn's disease in Asia

TitleBest practices on immunomodulators and biological agents for Ulcerative colitis and Crohn's disease in Asia
Authors
Ooi, CJHilmi, IBanerjee, RChuah, SWNg, SCWei, SCMakharia, GKPisespongsa, PChen, MHRan, ZHYe, BDPark, DILing, KLOng, DAhuja, VGoh, KLSollano, JLim, WCLeung, WKRaja Ali, RAWu, DCOng, EMustaffa, NLimsrivilai, JHisamatsu, TYang, SKOuyang, QGeary, RDe Silva, JHRerknimitr, RSimadibrata, MAbdullah, MLeong, RWL
Keywordsadalimumab
biosimilar
Crohn's disease
inflammatory bowel disease
infliximab
ulcerative colitis
Issue Date2019
PublisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH
Citation
Journal of Gastroenterology and Hepatology, 2019, v. 34 n. 8, p. 1296-1315 How to Cite?
DOI: http://dx.doi.org/10.1111/jgh.14648
DescriptionLink to Free access
Persistent Identifierhttp://hdl.handle.net/10722/269554
ISSN
0815-9319
2021 Impact Factor: 4.369
2020 SCImago Journal Rankings: 1.214
ISI Accession Number ID
WOS:000483697100010

 

DC FieldValueLanguage
dc.contributor.authorOoi, CJ-
dc.contributor.authorHilmi, I-
dc.contributor.authorBanerjee, R-
dc.contributor.authorChuah, SW-
dc.contributor.authorNg, SC-
dc.contributor.authorWei, SC-
dc.contributor.authorMakharia, GK-
dc.contributor.authorPisespongsa, P-
dc.contributor.authorChen, MH-
dc.contributor.authorRan, ZH-
dc.contributor.authorYe, BD-
dc.contributor.authorPark, DI-
dc.contributor.authorLing, KL-
dc.contributor.authorOng, D-
dc.contributor.authorAhuja, V-
dc.contributor.authorGoh, KL-
dc.contributor.authorSollano, J-
dc.contributor.authorLim, WC-
dc.contributor.authorLeung, WK-
dc.contributor.authorRaja Ali, RA-
dc.contributor.authorWu, DC-
dc.contributor.authorOng, E-
dc.contributor.authorMustaffa, N-
dc.contributor.authorLimsrivilai, J-
dc.contributor.authorHisamatsu, T-
dc.contributor.authorYang, SK-
dc.contributor.authorOuyang, Q-
dc.contributor.authorGeary, R-
dc.contributor.authorDe Silva, JH-
dc.contributor.authorRerknimitr, R-
dc.contributor.authorSimadibrata, M-
dc.contributor.authorAbdullah, M-
dc.contributor.authorLeong, RWL-
dc.date.accessioned2019-04-24T08:10:04Z-
dc.date.available2019-04-24T08:10:04Z-
dc.date.issued2019-
dc.identifier.citationJournal of Gastroenterology and Hepatology, 2019, v. 34 n. 8, p. 1296-1315-
dc.identifier.issn0815-9319-
dc.identifier.urihttp://hdl.handle.net/10722/269554-
dc.descriptionLink to Free access-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/JGH-
dc.relation.ispartofJournal of Gastroenterology and Hepatology-
dc.rightsThis is the peer reviewed version of the following article: [Journal of Gastroenterology and Hepatology, 2019, v. 34 n. 8, p. 1296-1315], which has been published in final form at [http://dx.doi.org/10.1111/jgh.14648]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.subjectadalimumab-
dc.subjectbiosimilar-
dc.subjectCrohn's disease-
dc.subjectinflammatory bowel disease-
dc.subjectinfliximab-
dc.subjectulcerative colitis-
dc.titleBest practices on immunomodulators and biological agents for Ulcerative colitis and Crohn's disease in Asia-
dc.typeArticle-
dc.identifier.emailLeung, WK: waikleung@hku.hk-
dc.identifier.authorityLeung, WK=rp01479-
dc.description.naturepostprint-
dc.identifier.doi10.1111/jgh.14648-
dc.identifier.scopuseid_2-s2.0-85068412382-
dc.identifier.hkuros297574-
dc.identifier.volume34-
dc.identifier.issue8-
dc.identifier.spage1296-
dc.identifier.epage1315-
dc.identifier.isiWOS:000483697100010-
dc.publisher.placeAustralia-
dc.identifier.issnl0815-9319-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats